SCHEMBL18398373

SCHEMBL18398373

CCc1ccc(OC(F)F)cc1N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC3 O15379 1/20 0.42
▸ HDAC4 P56524 1/20 0.42
▸ HDAC1 Q13547 1/20 0.42
▸ HDAC7 Q8WUI4 1/20 0.42
▸ HDAC2 Q92769 1/20 0.42
▸ HDAC10 Q969S8 1/20 0.42
▸ HDAC11 Q96DB2 1/20 0.42
▸ HDAC8 Q9BY41 1/20 0.42
▸ HDAC6 Q9UBN7 1/20 0.42
▸ HDAC9 Q9UKV0 1/20 0.42
▸ HDAC5 Q9UQL6 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ ALOX15 P16050 1/20 0.40
▸ GFER P55789 1/20 0.40
▸ ADAM17 P78536 1/20 0.40
▸ EPHX2 P34913 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ LMNA P02545 1/20 0.38
▸ POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20494966 0.81 ALDH1A1 (0.41) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL24987666 0.79 APLNR (0.46) EPHX2PKMLMNAPOLBALDH1A1
SCHEMBL29373010 0.78 NR4A1 (0.56) ALOX15GFERADAM17HTTPKM
SCHEMBL5951484 0.78 NR4A1 (0.56) ALOX15GFERADAM17HTTPKM
SCHEMBL14183050 0.78 SMN1; SMN2 (0.44) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL24587311 0.78 PPARG (0.40) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL29502984 0.77 ALDH1A1 (0.45) L3MBTL1ALOX15GFERADAM17HTT
SCHEMBL18702751 0.77 ALDH1A1 (0.45) L3MBTL1ALOX15GFERADAM17HTT
SCHEMBL23841500 0.76 KDM4E (0.49) L3MBTL1ALOX15GFERADAM17ALDH1A1
Hydrochloric Acid SCHEMBL9526180 0.76 NR4A1 (0.54) ALOX15GFERADAM17HTTPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017012647-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2017-01-26 — — WO disclosed
WO-2017012647-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2017-01-26 — — WO disclosed
Send feedback